当前位置: X-MOL首页全球导师 国内导师 › Douglas Xiaohua ZHANG

个人简介

Education EMBA Guanghua School of Management, Peking University Beijing, China (2017) PhD Carnegie Mellon University Pittsburgh, PA (2002) PhD student (ABD) Texas A & M University College Station,TX (1997-1998) MS Beijing Normal University Beijing, China (1996) BS Beijing Normal University Beijing, China (1990) Academic and Professional Experience 2016-present Professor, Faculty of Health Sciences, University of Macau 2015-2016 Senior Principal Scientist, Merck Research Laboratories, West Point, PA. 2012-2014 Director of BARDS and Head of Early Development Statistics – Asian Pacific, Merck Research Laboratories, West Point, PA. 2008-2012 Associate Director, Merck Research Laboratories, West Point, PA. 2005-2008 Senior Biometrician, Merck Research Laboratories, West Point, PA. 2002-2005 Biometrician, Merck Research Laboratories, West Point, PA. Expert for Professional Evaluation 2014 Expert for evaluation of Horizon 2020 grant proposals on topic “development of new diagnostic tools and technologies: in vitro devices, assays and platforms”, remotely 2011(November) Expert for evaluation of grant proposals for – omics for rare diseases Panel for the European Union 7th Framework Programme Health Theme, Brussels, Belgium 2011(March) Expert for evaluation of grant proposals for Large-Scale Data Gathering Panel for the EU 7th Framework Programme Health Theme, remotely 2011 Expert for evaluation in NIH Assay Development for High Throughput Molecular Screening Study Section, Santa Monica, California,USA 2009 Expert for evaluation of grant proposals for the EU 7th Framework Programme Health Theme, remotely 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014 Student Paper Competition Committee member and evaluator, ASA Biopharmaceutical Section Editorial Services for Peer-Reviewed Professional Journals 2012, Guest Editor, special issue in Journal of Probability and Statistics December 2010 – Present, Editorial Board Member, Journal of Biometrics & Biostatistics June 2010 – Present, Editorial Board Member, Journal of Pharmacogenomics and Pharmcoproteomics Referee for Peer-Reviewed Professional Journals November 2017, January 2013, November 2012, October, September & January 2011, October 2008, Bioinformatics August 2017, Statistical Methods in Medical Research July 2017, Mathematical Problems in Engineering June 2017, The FASEB journal January 2016, August 2015, International Journal of Biological Sciences June 2015, Computer Methods and Programs in Biomedicine March 2014, Advances in Genomics and Genetics February 2014, December 2013, Methods August 2013, PLOS ONE June & January 2013, PLOS Computational Biology January 2013, November 2012, October, September & January 2011, October 2008, Bioinformatics November & September 2013, January 2012, December, July 2010, Journal of Biomolecular Screening May 2011, Current Chemical Genomics January 2013, November 2010, December 2008, November 2007, IMECS Proceeding January 2010, November 2009, BMC Bioinformatics October 2009, January 2009, Statistics in Biopharmaceutical Research August 2009, Nature April 2009, Nature Methods January 2009, BMC Genomics January 2008, April 2007, Journal of American Statistical Association January 2005, Biometrical Journal September 2003, Annals of Human Genetics Professional Meeting Services 2016, 2015, 2014, 2013, 2012, 2011, 2010, Program Committee member for International Conference on Information Science and Applications, Seoul, Korea 2016, 2015, 2014, 2013, 2012, 2011, 2010, 2009, 2008, 2007, Program Committee member for the International MultiConference of Engineers and Computer Scientists, Hong Kong 2016, 2015, 2014, 2013, 2012, 2011, 2010, 2009, 2008, 2007, Conference Committee member for the IAENG International Conference on Bioinformatics, Hong Kong 2013, Organizer, Special session, “Statistics in biopharmaceutical research”, the 59th World Statistics Congress, Hong Kong 2010, Chair and organizer, Roundtable session ‘High-throughput screening and data analysis’, The Joint Statistical Meetings, Vancouver, Canada 2010, Chair and organizer, Special session ‘Data Analysis in Genome-scale RNAi Researches’, International Conference on Intelligent Systems for Molecular Biology, Boston, MA, USA. July 2008, chaired a session “Omics and System Biology for Antiviral Drug Discovery” in BIT’s 1st Annual World Summit of Antivirals. Kunming, China June 2008, organized and chaired invited session “Statistics for Biotechnology” in the First Symposium of The International Society for Biopharmaceutical Statistics, Shanghai, China August 2007, organized invited session “Data analysis in High Throughput Screening Assays” in the Joint Statistical Meetings, Salt Lake City, UT June 2006, chaired session “SESSION 8-BIOCOMP: INTELLIGENT DRUG DESIGN” in the International Conference on Bioinformatics & Computational Biology, Las Vegas, Nevada August 2005, organized and chaired invited session “Pharmacogenomics” in the Joint Statistical Meetings, Minneapolis, MN, USA August 2005, organized and chaired luncheon roundtable “Pharmacogenomics: the Critical path to Personalized Medical Products” in the Joint Statistical Meetings, Minneapolis, MN August 2004, organized contributed session “Microarray” for the Joint Statistical Meetings, Toronto, Ontario August 2003, organized and chaired contributed session “Genetics Data Analysis I” in the Joint Statistical Meetings, San Francisco, CA Course Outlines HSCI3003 Biostatistics and Experimental Design HSCI7001 Artificial Intelligence In Medicine

研究领域

Prof. Zhang’s lab focuses on research in digital health/medicine, artificial intelligence and big data analysis. Current research in this area includes, but not limited to, conducting studies in continuous monitoring of physiological signals (such as blood glucose, respiratory signals, cardiovascular signals) and high-throughput genomics (such as CRISPR/CAS9 HTS and RNA-seq) to address medical questions in diabetes, respiratory diseases, cardiovascular diseases, neuro-diseases, cancers and so on. Critical research also includes the development of novel experimental designs, analytic methodology and software (including R packages) for analyzing big data in digital health/medicine and precision medicine. Prof. Zhang has worked in quantitative high-throughput genotyping/phenotyping for about 20 years. The novel methods developed by him and his colleagues along with their applications have a high impact on the high-throughput screening research field, especially in RNAi high-throughput screening (HTS) research.

近期论文

查看导师最新文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

Representative Publications Zhang XD, Optimal High-Throughput Screening: Practical Experimental Design and Data Analysis for Genome-scale RNAi Research. Cambridge University Press, Cambridge, UK (ISBN: 9780521734448 or 9780521517713, amazon.com). Zhang XD#*, Zhang Z#, Wang 2018. CGManalyzer: an R package for analyzing continuous glucose monitoring studies. Bioinformatics 34(9): 1609–1611 (DOI: 10.1093/bioinformatics/btx826) Niu J#, Shi Y#*, Cai M, Cao Z, Wang D, Zhang Z, Zhang XD*. 2018. Detection of sputum by interpreting the time-frequency distribution of respiratory sound signal using image processing techniques. Bioinformatics 34(5): 820-827 (DOI: 10.1093/bioinformatics/btx652) Zhang XD*, Santini F, Lacson R, Marine SD, Wu Q, Benetti L, Yang R, McCampbell A, Berger JP, Toolan DM, Stec EM, Holder DJ, Soper KA, Heyse JF and Ferrer M. 2011. cSSMD: Assessing collective activity of multiple siRNAs in genome-scale RNAi screens. Bioinformatics 27(20): 2775-2781 (doi: 10.1093/bioinformatics/BTR474). +listed among the 50 most-frequently cited articles in Bioinformatics in 2013 Zhang XD*, Zhang Z. 2013. displayHTS: a R package for displaying data and results from high-throughput screening experiments. Bioinformatics 29 (6): 794–796 (doi: 10.1093/bioinformatics/btt060). Zhang XD*, Heyse JF. 2009. Determination of sample size for hit selection in genome-scale RNAi screens. Bioinformatics 25: 841-844 (doi:1093/bioinformatics/btp082) Zhang XD*, Kuan PF, Ferrer M, Shu X, Liu YC, Gates AT, Kunapuli P, Stec EM, Xu M, Marine SD, Holder DJ, Stulovici B, Heyse JF, Espeseth AS. 2008. Hit selection with false discovery rate control in genome-scale RNAi screens. Nucleic Acids Research 36 (14):4667-4679 (doi:1093/nar/gkn435). Zhou H, Xu M, Huang Q, Gates AT, Zhang XD, Stec EM, Ferrer M, Hazuda DJ, Espeseth AS. 2008. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host & Microbe 4(5):495-504 (doi:1016/j.chom.2008.10.004).+listed by Nature Medicine in its year end review on Notable advances in 2008 (http://www.nature.com/nm/journal/v14/n12/full/nm1208-1302.html)+selected to appear in the cover page of the November issue of Cell Host & Microbe Shi Y#, Wang G#, Niu J*, Zhang Q, Cai M, Sun B, Wang D, Xue M, Zhang XD*. 2018. Classification of sputum sounds using artificial neural network and wavelet transform. International Journal of Biological Sciences 2018; 14(8): 938-945 (DOI: 10.7150/ijbs.23855) Ren S, Cai M, Shi Y*, Xu W, Zhang XD*, 2017. Influence of bronchial diameter change on the airflow dynamics based on a pressure-controlled ventilation system. International Journal for Numerical Methods in Biomedical Engineering: e2929 (doi: 10.1002/cnm.2929) Jin Y#, Chen C#, Cao Z, Sun B, Lo IL, Liu TM, Zheng J, Sun S, Shi Y*, Zhang XD*. 2017. Entropy change of biological dynamics in human chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Diseases 12: 2997–3005 (doi: 2147/COPD.S140636) Zhao G, Li Q, Wang IM, Li X, Fang X, Zhang XD*. 2015. An effective analytic method for detecting tissue-specific genes from RNA-seq data. Pharmacogenomics 16 (16):1769-1779 (doi: 10.2217/pgs.15.118). Gould AL*, Zhang XD. 2014. Bayesian adaptive determination of the sample size required to assure acceptably low adverse event risk. Statistics in Medicine 33(6): 940-957 (DOI: 10.1002/sim5993) Zhang XD*, Heyse JF. 2012. Contrast variable for comparing groups in biopharmaceutical research. Statistics in Biopharmaceutical Research 4 (3): 228 – 239 (DOI: 10.1080/19466315.2011.646905). Zhang XD*. 2011. Illustration of SSMD, z-score, SSMD*, z*-score and t-statistic for hit selection in high-throughput screens. Journal of Biomolecular Screening 16 (7): 775 – 785 (doi: 10.1177/1087057111405851).+listed among the 50 most-frequently cited articles in Journal of Biomolecular Screening since 2014 Zhao WQ, Santini F, Breese R, Ross D, Zhang XD, Stone DJ, Ferrer M, Townsend M, Wolfe AL, Seager MA, Kinney GG, Shughrue PJ, Ray WJ. 2010. Inhibition of calcineurin-mediated endocytosis and AMPA receptor prevent amyloid β oligomer-induced synaptic disruption. Journal of Biological Chemistry 285(10): 7619-7632 (doi:1074/jbc.M109.057182). Zhang XD*. 2010. Assessing the size of gene or RNAi effects in multi-factor high-throughput experiments. Pharmacogenomics 11(2): 199 – 213 (doi:10.2217/PGS.09.136) Zhang XD*. 2010. Strictly standardized mean difference, standardized mean difference and classical t-test for the comparison of two groups. Statistics in Biopharmaceutical Research 2(2): 292-299 (doi: 1198/sbr.2009.0074) Zhang XD*. 2009. A method effectively comparing gene effects in multiple conditions in RNAi and expression profiling research. Pharmacogenomics 10(3):345-358 (doi:10.2217/14622416.10.3.345) Zhang XD*, Espeseth AS, Johnson E, Chin J, Gates A, Mitnaul L, Marine SD, Tian J, Stec EM, Kunapuli P, Holder DJ, Heyse JF, Stulovici B, Ferrer M. 2008. Integrating experimental and analytic approaches to improve data quality in genome-wide RNAi screens. Journal of Biomolecular Screening 13(5): 378-389 (doi: 1177/1087057108317145).+selected to appear in the cover page of the June issue Zhang XD*, 2008. Novel analytic criteria and effective plate designs for quality control in genome-wide RNAi screens. Journal of Biomolecular Screening 13(5): 363-377 (doi:1177/1087057108317062) +listed among the 50 most-frequently cited articles in Journal of Biomolecular Screening since 2013 (http://jbx.sagepub.com/reports/most-cited) Chung N, Zhang XD, Kreamer A, Locco L, Kuan PF, Bartz S, Linsley PS, Ferrer M, Strulovici B. 2008. Median absolute deviation to improve hit selection for genome-scale RNAi screens. Journal of Biomolecular Screening 13: 149-158 (doi: 1177/1087057107312035). +listed among the 50 most-frequently cited articles in Journal of Biomolecular Screening since 2011 Zhang XD*. 2007. A new method with flexible and balanced control of false negatives and false positives for hit selection in RNA interference high throughput screening assays. Journal of Biomolecular Screening 12 (5): 645-655 (doi:1177/1087057107300645) +listed among the 50 most-frequently cited articles in Journal of Biomolecular Screening since April 2009 Zhang XD*, Ferrer M, Espeseth AS, Marine SD, Stec EM, Crackower MA, Holder DJ, Heyse JF, Strulovici B. 2007. The use of strictly standardized mean difference for hit selection in primary RNA interference high throughput screening experiments. Journal of Biomolecular Screening 12 (4): 497-509 (doi:1177/1087057107300646). +listed among the 50 most-frequently cited articles in Journal of Biomolecular Screening since 2008 Zhang XD*. 2007. A pair of new statistical parameters for quality control in RNA interference high throughput screening assays. Genomics 39: 552-561 (doi: 1016/j.ygeno.2006.12.014). Zhang XD*, Yang XC, Chung N, Gates AT, Stec EM, Kunapuli P, Holder DJ, Ferrer M, Espeseth AS. 2006. Robust statistical methods for hit selection in RNA interference high throughput screening experiments. Pharmacogenomics 7 (3) 299-309 (doi: 2217/14622416.7.3.299). Johnson TE, Zhang XD, Shu S, Umbenhauer DR. 2005. Statins and PPARagonists induce myotoxicity in differentiated rat skeletal muscle cultures but do not exhibit synergy with co-treatment. Toxicology and Applied Pharmacology 208 (3) 210-221 (PMID: 16239165). Roeder K, Bacanu S, Sonpar V, Zhang XD, Devlin B. 2005. Analysis of Single-Locus Tests to Detect Gene/Disease Associations. Genetic Epidemiology 28 (3) 207-219 (PMID: 15637715) Johnson TE, Zhang XD, Bleicher KB, Dysart G, Loughlin AF, Schaefer WH, Umbenhauer DR. 2004. Statins induce apoptosis in rat and human myotube cultures by inhibiting protein geranylgeranylation but not ubiquinone. Toxicology and Applied Pharmacology 200 (3): 237-250 (PMID: 15504460). Zhang XD, Roeder K*, Wallstrom G, Devlin B. 2003. Integration of association statistics over genomic regions using Bayesian adaptive regression splines. Human Genomics 1: 20-29 (doi:1186/1479-7364-1-1-20; PMID: 15601530 link).

学术兼职

2016 – Present IEEE 2015 – Present American Association for the Advancement of Science 2014 – Present Executive Committee Member, Functional Genomics and System Biology, Chinese Society for Cell Biology 2014 – Present Chairperson, Biopharmaceutical Section,Functional Genomics and System Biology, Chinese Society for Cell Biology 2014 – Present Vice Chairperson, Specialty Committee of Reproductive Medicine,World Federation of Chinese Medicine Society 2002 – Present American Statistical Association 2012 – 2015 Core member of the DIA China Statistics SIAC 2012-2014 Committee Member, Functional Genomics and System Biology, Chinese Society for Cell Biology

推荐链接
down
wechat
bug